RICOVR Healthcare’s Post

Applications are now open for the LifeX Accelerator Spring 2024 cohort! The LifeX Accelerator is a 3 month structured program for early stage startups in digital health, medical devices, diagnostics, and therapeutics. Our curriculum is curated to meet the unique needs of companies innovating in the complex healthcare environment and is delivered by a broad network of 70+ expert contributors including successful entrepreneurs, investors, and domain experts. This program will give you the tools to excel as an industry leader, validate your business model, jumpstart your plan to commercialization, and help you prepare for your initial fundraising. Intrigued? Learn more about the LifeX Accelerator Program and apply to take your business to the next level: https://lnkd.in/d-RvAat5

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/gdvqY4ZP #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/gj3rzaD3 #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/gtee2nYe #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL

Have a New Year's resolution to save time and money? Transform your clinical trial processes with PROPEL and your organization could save nearly 30 hours per week! According to an analysis by one of our leading IRO clients, PROPEL saves their organization an average of 29.7 hours per week (based on 100 new trial activations a year). Accelerate clinical trial processes, automate study startup, respond to more trial opportunities, and save time and money across the board with PROPEL! Get started today! https://lnkd.in/e5WNVw7C #resolution #clinicaltrials #clinicalresearch #clinicaltrialsoftware #PROPEL

“You've got to balance the idea that the doctors that first work with you are going to understand that they have technology that isn't complete, that this isn't the final generation. But you need to have developed it in such a way that there is a real path to that final version.” Dan Rose is back on Medsider to share his proven #medtech insights after LimFlow SA’s recent exit to Inari Medical. With 25 years of experience in both startups and industry giants like Medtronic, Dan talks about M&A transactions, engaging with investors while maintaining business autonomy, and the importance of developing your #medicaldevice with the average user in mind. LimFlow’s technology tackles Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) – conditions where blocked arteries threaten limb viability and may potentially lead to amputation. Instead of trying to open blockages, LimFlow ingeniously reroutes blood flow through adjacent veins, restoring circulation and offering hope to patients who suffer from this disease. Here’s a sneak peek into his interview with Scott Nelson: ⚖️ Vet your potential investors carefully and consider how their involvement will impact your business operations, especially if there are multiple parties involved. Limit their influence on decision-making to maintain flexibility and control over your company's direction. 🥼 In the early development phases, design for the average user to maximize adoption rates. Always iterate towards simplicity and be prepared to pivot accordingly. And don't hold onto complex elements or features simply because they were part of the original plan. 💵 Understanding the reimbursement landscape and how your technology fits into that is crucial to progress your conversations with VCs. Research potential investors to ensure that they have the capacity to invest and that their interests match your company's focus. Click on the link in the comments section to follow Dan’s journey building and exiting LimFlow. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume V, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

If you're stuck at this stage & don't know what your next step should be, check out this blog by the Director of our 1099 Accelerator Program: https://lnkd.in/gN8dJqeg #Medtech #MedicalDevice #1099

Verge Healthtech Fund is gearing up for three dynamic panel discussions at DTX ASIA 2023 tomorrow! First, head to the "Keynote Panel Discussion: Why Bring DTx to Asia?" on the morning of Nov 29. Listen to our Managing Partner, Scarlett Chen 陈思佳, and her co-panelists delve into success factors for digital therapeutics and its adoption in Asia, accessibility in low-resource settings, and integration with other health tools. 🌏 Then in the afternoon, join our co-founder and Managing Partner, Joseph Mocanu, for the “A One Stop Shop on What A Digital Health Investor Seeks in a DTx Company" panel, where he and his co-panelists will explore the landscape of DTx investments, how they balance profitability with impact, and how to foster successful collaborations between DTx companies and investors. 🤝 The following morning on Nov 30, catch our co-founder and General Partner, Ed Deng, appearing in the “Panel Discussion: Identifying the Gaps in DTx: What is the Industry Missing?” Ed will be representing his startup, Health2Sync 智抗糖, a comprehensive health management platform helping chronic disease patients improve their health conditions with personalized digital therapeutics.🩸 Whether you're a startup on a mission to solve global health challenges through digital therapeutics, or a fellow investor of impactful healthtech startups, we invite you to connect. We’ll be at the summit until Nov 30. 👥 #dtx #dtxasia #digitalhealth #digitaltherapeutics

The #NotifiedBody plays a central role in the process of becoming a medical device manufacturer. We spoke to Dietmar Schaffarczyk, auditor at QS Schaffhausen AG, to find out more about what the NB expects from young #MedTech startups.   Our key takeaways: ◾ NBs must maintain their independence in their assessments, which is why they must not offer direct advice. ◾ While each company must be compliant, NBs take into account the current status of a company. ◾ Long-term success can only be guaranteed by building internal expertise in addition to external support. ◾ When you first contact an NB for a QMS audit, for example, 65% of the documentation should be ready. Read the full interview here 👉 https://lnkd.in/gTvz9a5e

“You can’t know everything. Even if you could, your community, your support in the startup world, is really, really important to ensure that you're making the right decisions, because one mistake can cost everything. Surrounding yourself with people is a really solid way to make sure that you're on the right path.” Meet Tyler Melton, co-founder and CEO of Houston-based Corveus Medical. Tyler and his team are taking an ambitious plunge into remedying congestive heart failure with a catheter-based device for nerve ablation. Here are a few takeaways from Tyler’s conversation with Scott Nelson: ➡ Use off-the-shelf products for prototyping to save time and money. Tap into existing expertise and networks to drive progress rather than trying to solve everything yourself in a silo. ➡ Accelerator programs provide startups with vital networking opportunities and force them to validate or adjust their business assumptions. Tyler shares insights on evaluating the costs of these programs in equity, time, and other commitments. ➡ Opting for the PMA route, despite its rigor and scrutiny, can offer a focused approach to proving clinical efficacy. When it comes to fundraising, early planning paired with targeted investor engagement can help you navigate hurdles efficiently. Catch the full conversation to hear about Tyler’s journey: (link in comments) This Medsider episode was brought to you by HENDOSYN, your strategic ally in clinical affairs with a Latin-American focus. They offer comprehensive clinical services — from strategy development to clinical trial management, outcomes research, and even local commercialization. All of this is led by experienced physicians, to accelerate timelines, minimize risks, and fast-track enrollment for medtech startups. Learn more details through the link in the comments. P.S. - We recently launched Medsider Mentors Volume IV, which is chock full of insights and learnings from founders and CEOs of some of the most dynamic #medicaldevice and health technology startups in the world. Click the link in the comment section for this latest edition, now available exclusively for our premium members.